Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local gentamicin for prevention of cardiac pacemaker implant infection
RBR-33dd28cPhase 2Completed
- Sponsor
- UniSALESIANO
- Start
- Aug 2024
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cardiac Device Infection (CIEDI) comparing Local gentamicin with Placebo (2 arms). Primary endpoint: Occurrence of outcomes of interest on clinical follow-up. Started Aug 2024; status: completed.
02
Drugs
gentamicin
03
Conditions
Cardiac Device Infection (CIEDI)
Beyond the preview
Go deeper on RBR-33dd28c.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-33dd28c.